Open AccessP1361: TREATMENT OF SEVERE STEROID‐REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE‐BLIND MULTI‐CENTER HOVON‐113 TRIAL
Author(s) -
Oosten L.,
Pel M.,
Holt B.,
Bach E.,
Cross M.,
Roelofs H.,
Meij P.,
Wieles B.,
Zwaginga J. J.,
Lankester A.,
Veelken H.,
Platzbecker U.,
SanchezGuijo F.,
Algeri M.,
Locatelli F.,
Devos T.,
Cornelissen J.,
Niederwieser D.,
Fibbe W.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000848304.76865.3a
Subject(s) - medicine , clinical endpoint , placebo , gastroenterology , concomitant , transplantation , adverse effect , graft versus host disease , refractory (planetary science) , cumulative incidence , randomized controlled trial , single center , surrogate endpoint , pathology , physics , astrobiology , alternative medicine